#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chorioretinitis Malignant peritoneal neoplasm Acute hepatic failure Infantile spasms Burkitt's lymphoma Glycogen storage disease type II Rectal cancer Kaposi's sarcoma Behcet's syndrome Gastrointestinal disorder Kearns-Sayre syndrome Amyloidosis Thalassaemia Metastatic gastric cancer Systemic sclerosis pulmonary More trials…

    Learn about Rare Diseases

    Epidermolysis bullosa – Diagnostics Isodicentric chromosome 15 syndrome Chronic granulomatous disease – Life with Disease Mast cell activation syndrome Mucopolysaccharidosis III – Diagnostics Piriformis syndrome – Basic Information Metachromatic leukodystrophy CADASIL – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lacutamab Nusinersen Gadobenate Dimeglumine Methotrexate Disodium [18F]Fluoro-Peg-Folate Dyp688 Adrc001 Almagate Tislelizumab Sildenafil Psilocybine Lbl-007 Arachis Hypogaea Extract 1,3-BUTYLENE GLYCOL Corticosteroids, Plain Fluticasone Propionate Brinzolamide GSK5733584 AB521 Ethambutol More therapies…

    Learn about Your Condition

    Cytokine release syndrome Cervix carcinoma stage II Lung disorder Sickle cell disease Adrenocortical carcinoma Oropharyngeal cancer recurrent Schizophreniform disorder Chorea Macular oedema Congenital myopathy Albright's disease Infertility Premature baby Cortisol abnormal Metabolic surgery More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on the Effects of Oral Semaglutide on Bone Health in Patients with Type 2 Diabetes and Low Bone Mass

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Placebo
    • Semaglutide
    • Tetracycline Hydrochloride
    Denmark

  • Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Czechia Germany Greece

  • Study on the Effects of Siplizumab in Adults with New Onset Type 1 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Siplizumab
    • Cetirizine Dihydrochloride
    • Paracetamol
    Belgium Italy Spain Sweden

  • Study on the Effects of Retatrutide for Patients with Obesity, Overweight, or Knee Osteoarthritis

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    • Osteoarthritis
    Investigated Drugs:
    • Ly3437943 Sodium
    Hungary Poland Romania Spain

  • Study on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Insulin Glargine
    • Insulin Icodec
    • Metformin
    Greece Italy Poland

  • Study of BMS-986449 and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant mast cell neoplasm
    Investigated Drugs:
    • Bms-986449-03
    • Nivolumab
    Belgium France Italy The Netherlands Spain
Previous Page
1 … 51 52 53 54 55 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!